Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy

The ability to use mesenchymal stromal cells (MSC) directly out of cryostorage would significantly reduce the logistics of MSC therapy by allowing on-site cryostorage of therapeutic doses of MSC at hospitals and clinics. Such a paradigm would be especially advantageous for the treatment of acute con...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramlich, Oliver W., Burand, Anthony J., Brown, Alex J., Deutsch, Riley J., Kuehn, Markus H., Ankrum, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876464/
https://www.ncbi.nlm.nih.gov/pubmed/27212469
http://dx.doi.org/10.1038/srep26463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876464/
https://www.ncbi.nlm.nih.gov/pubmed/27212469
http://dx.doi.org/10.1038/srep26463

Ejemplares similares